Meta‐analysis of memantine: Summary and commentary on the Cochrane Collaboration's systematic review

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Alzheimer's & Dementia

• Publication date

  2005-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.jalz.2005.06.025PMID 19595819
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Memantine for dementia.

  2006cited by this paper
• Memantine for dementia.

  2005cited by this paper
• Memantine for dementia.

  2005cited by this paper
• Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies

  2005cited by this paper
• P1-021 Memantine treatment for mild to severe Alzheimer's disease: clinical trials summary

  2004cited by this paper
• Interventions for replacing missing teeth: different times for loading dental implants.

  2004cited by this paper
• Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.

  2004cited by this paper
• P4.022 Memantine monotherapy is effective andsafe for the treatment of mild to moderate Alzheimer's disease: A randomized controlled trial

  2004cited by this paper
• Memantine in moderate-to-severe Alzheimer's disease.

  2003cited by this paper
• Memantine in moderate-to-severe Alzheimer's disease.

  2003cited by this paper
• Efficacy and Safety of Memantine in Patients With Mild to Moderate Vascular Dementia: A Randomized, Placebo-Controlled Trial (MMM 300)

  2002cited by this paper
• A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500)

  2002cited by this paper
• A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease

  2001cited by this paper
• Memantine in severe dementia: results of the 9M‐best study (benefit and efficacy in severly demented patients during treatment with memantine)

  1999cited by this paper
• Memantine in the treatment of mild to moderate dementia syndrome. A double-blind placebo-controlled study.

  1992cited by this paper
• Efficacy and tolerability of memantine in patients with dementia syndrome. A double-blind, placebo controlled trial.

  1991cited by this paper

• Hydromethylthionine enhancement of central cholinergic signalling is blocked by rivastigmine and memantine

  2021cites this paper
• Effects of systemic and intra-accumbal memantine administration on the impacts of plantar electrical shock in male NMRI mice

  2014cites this paper
• Using Genetics to Enable Studies on the Prevention of Alzheimer's Disease

  2013cites this paper
• Memantine effects on liver and adrenal gland of rats exposed to cold stress

  2011cites this paper
• Managing Cognitive Dysfunction through the Continuum of Alzheimer’s Disease

  2011cites this paper
• Memantine effects on liver and adrenal gland of rats exposed to cold stress.

  2011cites this paper
• Commentary on “Meta‐analysis of six‐month memantine trials in Alzheimer's disease.” Wuthering forest plots: Distinguishing the forest from the plots

  2007cites this paper
• A double‐blind, placebo‐controlled trial of memantine in age‐associated memory impairment (memantine in AAMI)

  2007cites this paper
• Effect of galantamine on verbal repetition in AD

  2007cites this paper
• Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease

  2006cites this paper
• Commentary on “Meta‐analysis of memantine: Summary and commentary on the Cochrane Collaboration's systematic review.” Meaning and measurement in cognitive impairment

  2006cites this paper
• Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

  2006cites this paper